The Country of Origin of Menthol Cough Drops
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Ruling text
In your letter, dated September 16, 2025, you requested a country of origin determination on behalf of your client, Altray Company Inc. (Stamford, CT). The subject merchandise is described as Menthol Cough Drops. The cough drops are said to contain pharmaceutical grade menthol pellets that are manufactured in the United States.
The cough drops’ ingredients include sucrose (53.2 percent), corn syrup (43.7 percent), water (2.5 percent), the aforementioned menthol (0.22 percent), soy lecithin (0.05 percent), maltodextrin (0.05 percent), gum arabic (0.03 percent), artificial color red 40 (0.02 percent), and artificial color blue 1 (0.01 percent).
The cough drops will be produced in Brazil by Riclan S.A. The U.S.-origin pharmaceutical-grade menthol pellets will initially be weighed and then processed into a syrup via heating, dissolving, and then adding water. The inactive ingredients in the cough drops will also be heated and dissolved to create a concentrated sugar base. Next, the menthol syrup will be mixed into the sugar base, placed into lozenge molds, and cooled to solidify the mixture into cough drops.
The drops will then be wrapped, stored in bulk for batch testing, bagged in individual packs, and boxed in shipping cartons for export to the United States. The cough drops will be sold in drug stores, national chains, and supermarkets. You seek a determination as to the country of origin of the above-described product. The “country of origin” is defined in 19 CFR 134.1(b) as “the country of manufacture, production, or growth of any article of foreign origin entering the United States.
Further work or material added to an article in another country must effect a substantial transformation in order to render such other country the ‘country of origin’ within the meaning of this part.” The test for determining whether a substantial transformation will occur is whether an article emerges from a process with a new name, character or use, different from that possessed by the article prior to processing. See Texas Instruments Inc. v. United States, 69 C.C.P.A. 151 (1982).
This determination is based on the totality of the evidence. See National Hand Tool Corp. v. United States, 16 C.I.T. 308 (1992), aff'd, 989 F.2d 1201 (Fed. Cir. 1993), and National Juice Products Association v. United States, 628 F. Supp. 978 (Ct. Int’l Trade 1986). In the present case, we find that according to the presented facts, the country of origin of the menthol cough drops is the United States, where the menthol is produced.
Processing operations in Brazil will not rise to the level of a substantial transformation. The menthol cough drops created by the manufacturing operation in Brazil will therefore be considered a product of the United States for duty purposes.
The question of whether the applicable merchandise at issue may be marked with a phrase such as “Product of U.S.A.” is under the jurisdiction of the U.S. Federal Trade Commission, Bureau of Consumer Protection, Division of Enforcement, which may be contacted for advice at 600 Pennsylvania Avenue N.W., Washington, D.C. 20580, or through the FTC’s website at http://www.ftc.gov.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N353822).